Cerevel Therapeutics
CERE
$42.20
Share price
0.30%
Change (1 day)
50.75%
Change (1 year)
Categories
EPS for Cerevel Therapeutics (CERE)
EPS in 2023 (TTM): -$2.50
According to Cerevel Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.50. In 2022 the company made an earnings per share (EPS) of -$2.32 a decrease over its 2021 EPS that were of -$1.65.
EPS history for Cerevel Therapeutics from 2020 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.50 | 7.76% |
| 2022 | -$2.32 | 40.61% |
| 2021 | -$1.65 | 36.84% |
| 2020 | -$1.21 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Archer Daniels Midland (ADM)
ADM | $7.21 | -388.52% | 🇺🇸 USA |
 Campbell Soup CPB | $2.88 | -215.20% | 🇺🇸 USA |
 Dow DOW | $1.84 | -173.60% | 🇺🇸 USA |
 Dupont De Nemours DD | $9.69 | -487.60% | 🇺🇸 USA |